Actualités 17. Apr. 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 17. Apr. 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
Success stories 04. Apr. 2024 Die spanische Pharmaindustrie kann neu von Schlangengift profitieren Pentapharm, ein wissenschaftsbasiertes Unternehmen mit Sitz im Raum Basel, ist ein international führender Anbieter von hochwertigen biochemische...
SWISS Pavilion SWISS Pavilion @ SIEE Pollutec 2024 10. Juni 2024–13. Juni 2024 Pins Maritimes Algerien
Success stories 04. Apr. 2024 Snake venum for the Spanish pharma industry Pentapharm, a science-based company located in the Basel area, is a leading international supplier of high-quality biochemical materials for vari...
News 29. Febr. 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
Fact Sheet 30. Okt. 2023 Opportunities for Swiss Companies in Projects of Metro and Railways in Chile In this this brochure you will find an introduction to the metro and railway system in Chile, an overview of the projects-pipeline worth 13,5bn U...
Webinar Infrastrutture ferroviarie in Croazia e Slovenia: i progetti attuali 11. Juni 2024 09:30–10:30 Schweiz
News 17. Mai 2024 Cowa Thermal Solutions closes financing round Cowa Thermal Solutions AG has successfully completed its second investment round. Due to high demand, the startup company from the canton of Luce...
Voyages pour PME Mission économique et commerciale de la Francophonie en Amérique du Nord 11. Juni 2024–13. Juni 2024
News 17. Apr. 2024 Symbio invests CHF 12 million in new research facility in Corminboeuf Symbio commits CHF 12 million to establish a high-tech hydrogen research center in Corminboeuf, aiming for a 2026 launch.